MAPT and chronic kidney disease: In BioFINDER-2, the effect of chronic kidney disease was examined and found to be significant (β[95%CI] = 0.54[0.39, 0.70], p < 0.001) on plasma NTA-tau when adjusting for age, sex and diagnosis.